8 May 2025

Aspanoa invests 120.000 euros to promote new immunotherapies for childhood cancer.

It will be distributed equally between two research projects. One is led by Diego Sánchez (IIS Aragón) and the other by Eva Gálvez (CSIC) and Ramón Hurtado (BIFI – Unizar). Immunotherapy is a treatment already being applied to some cancer patients, including children, when standard therapies are insufficient.
7 May 2025

The Zaragoza III Health Sector, recognized as a Center Committed to Excellence in Care

The designation ceremony, held on May 6 at the Lozano Blesa University Clinical Hospital, commemorated this international recognition with more than XNUMX attendees, three roundtable discussions with professionals and patients, and the presentation of official diplomas.
6 May 2025

A new experimental drug improves motor function and prolongs life in an ALS model.

The MP-010 molecule, developed by Miramoon Pharma, acts on ryanodine receptors, opening a new therapeutic avenue for treating ALS, according to a study led by researchers from CIBERNED and several research institutes, including the IIS Aragón.
2 May 2025

Conference 'Gambling, a Public Health Problem', May 9

The CaixaForum Zaragoza Auditorium will host a conference addressing gambling as a public health issue. The event will also present two innovative prevention projects, GAMBL-OUT and GAMBL-HID, led by researchers from the IIS Aragón.
30 April 2025

'I HumanizAR and CuidAR Awards for Aragon': recognition of the humanization of healthcare

The Government of Aragon, in collaboration with Roche, will award innovative initiatives in hospitals and healthcare centers that promote more humane and high-quality care. Projects can be submitted until June 24, 2025.